心理信息
医学
失眠症
人口
原发性失眠
安慰剂
临床试验
梅德林
随机对照试验
精神科
催眠药
物理疗法
睡眠障碍
替代医学
内科学
法学
病理
环境卫生
政治学
作者
Susanne Rösner,Christian Englbrecht,Renate Wehrle,Göran Hajak,Michael Soyka
出处
期刊:The Cochrane library
[Elsevier]
日期:2018-10-10
卷期号:2018 (10): CD010703-CD010703
被引量:49
标识
DOI:10.1002/14651858.cd010703.pub2
摘要
Eszopiclone appears to be an efficient drug with moderate effects on sleep onset and maintenance. There was no or little evidence of harm if taken as recommended. However, as certain patient subgroups were underrepresented in RCTs included in the review, findings might not have displayed the entire spectrum of possible adverse events. Further, increased caution is required in elderly individuals with cognitive and motor impairments and individuals who are at increased risk of using eszopiclone in a non-recommended way.
科研通智能强力驱动
Strongly Powered by AbleSci AI